Bionomics Ltd. ADR (NASDAQ:BNOX) traded with an addition of $2.52 to $3.51 on Thursday, an upside of 256.35 percent. An average of 13,261,991 shares of common stock have been traded in the last five days. There was a gain of $2.8950 in the past week, and it reached a new high 7 times over the past 12 months. The last 20 days have seen an average of 3,543,828 shares traded, while the 50-day average volume stands at 1,630,901.
BNOX stock has increased by 97.19% in the last month. The company shares reached their 1-month lowest point of $0.9300 on 09/26/23. With the stock rallying to its 52-week high on 03/07/23, shares of the company touched a low of $0.93 and a high of $10.90 in 52 weeks. It has reached a new high 4 times so far this year and lost -24.52% or -$0.7600 in price. In spite of this, the price is down -67.80% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
Bionomics Ltd. ADR (BNOX) has a trailing price-to-earnings (P/E) ratio of N/A for the broader industry. The stock’s beta is 0.83. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 150.75, the price-to-book (PB) ratio at 0.89.
Financial Health
The quick ratio of Bionomics Ltd. ADR for the recent quarter was 9.05, and the current ratio was 9.05, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.01 and a total debt to equity ratio of 0.01 for the recent quarter. Bionomics Ltd. ADR’s EBITDA margin is -9871.19%, while its operating margin for the same period stands at -11522.24%. Its gross profit as reported stood at $16.09 million compared to revenue of $0.19 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Bionomics Ltd. ADR’s return on assets was -39.11%.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Bionomics Ltd. ADR (BNOX) price momentum. RSI 9-day as of the close on 27 September was 86.79%, suggesting the stock is Overbought, with historical volatility in this time frame at 694.51%.
As of today, BNOX’s price is $1.5870 +290.95% or $2.8950 from its 5-day moving average. BNOX is currently trading +132.93% higher than its 20-day SMA and +65.54% higher than its 100-day SMA. However, the stock’s current price level is +58.78% above the SMA50 and -45.59% below the SMA200.
The stochastic %K and %D were 20.16% and 11.08%, respectively, and the average true range (ATR) was 0.7674. With the 14-day stochastic at 54.01% and the average true range at 0.5904, the RSI (14) stands at 80.69%. The stock has reached 0.5794 on the 9-day MACD Oscillator while the 14-day reading was at 0.4974.
Analyst Ratings
H.C. Wainwright launched coverage on Bionomics Ltd. ADR (NASDAQ: BNOX) in its analyst report released on January 10, 2022. The firm assigned the stock a Buy rating. The consensus rating for Bionomics Ltd. ADR (BNOX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell BNOX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.
What is BNOX’s price target for the next 12 months?
Analysts predict a range of price targets between $6.00 and $6.00, with a median target of $6.00. Taking a look at these predictions, the average price target given by analysts for Bionomics Ltd. ADR (BNOX) stock is $6.00.
